The Use of Risk Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-society Cholesterol Guidelines.
Anandita AgarwalaJing LiuChristie M BallantyneSalim S Virani
Published in: Current cardiovascular risk reports (2019)
The addition of the risk-enhancing factors to the pooled cohort equations provides a more individualized and comprehensive approach to cardiovascular disease risk assessment.